
ASND, GDS, ADSK and CDZI among after hours movers
15.37BUSD

See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US04351P1012
CUSIP
04351P101
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
26.70
PEG Ratio
-
Book Value
9.12
Dividend Share
-
Dividend Yield
-
Earnings Share
8.78
Wall Street Target Price
296.36
EPS Estimate Current Year
11.44
EPS Estimate Next Year
9.42
EPS Estimate Current Quarter
-0.148
EPS Estimate Next Quarter
0.5225
Most Recent Quarter
-
Revenue TTM
865,779,008
Gross Profit TTM
770,865,984
EBITDA
-10,224,000
Profit Margin
57.28%
Return On Assets TTM
-0.60%
Return On Equity TTM
33.27%
Revenue Per Share TTM
14.188
Qtly Revenue Growth YOY
144.30%
Diluted Eps TTM
8.78
Qtly Earnings Growth YOY
0.00%
Trailing PE
26.70
Forward PE
14
Price Sales TTM
17.7563
Price Book MRQ
26.747
Enterprise Value Revenue
15
Enterprise Value EBITDA
-20
892.26
1.57%458.99
1.28%300.44
1.09%157.77
0.76%282.72
0.29%900.00
0.00%72.38
-2.81%18.41
-2.02%607.93
-1.11%144.14
-0.55%